Ocular Rosacea
Ophthalmology·MeSH: Rosacea
6 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| XDEMVY (lotilaner ophthalmic solution) 0.25% | Tarsus Pharmaceuticals, Inc. (TARS) |
Phase 2(2)
Phase 4(3)
| Drug | Company |
|---|---|
| TP-04 (novel ophthalmic gel formulation of lotilaner) | Tarsus Pharmaceuticals, Inc. (TARS) |
| TP-05 (investigational oral tablet formulation of lotilaner) | Tarsus Pharmaceuticals, Inc. (TARS) |
| TP-05 (novel investigational oral formulation of lotilaner) | Tarsus Pharmaceuticals, Inc. (TARS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Ocular Rosacea?
BioSniper tracks 6 drugs in development for Ocular Rosacea across 1 company.
How many clinical trials target Ocular Rosacea?
There are 1 clinical trial targeting Ocular Rosacea tracked by BioSniper.
Analyze Tarsus Pharmaceuticals, Inc.'s Ocular Rosacea pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company